PAhR Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $14M

  • Investors
  • 3

PAhR Therapeutics General Information

Description

Operator of a clinical-stage biotechnology company intended to develop novel therapies for pulmonary arterial hypertension through molecular mechanisms. The company offers cutting-edge treatments targeting the molecular pathophysiology of PAH, enabling customers to access potentially life-saving therapies that address unmet needs in PAH treatment, offering new hope where conventional options fall short.

Contact Information

Website
www.pahrtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 200 Berkeley Street
  • Floor 18
  • Boston, MA 02116
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 200 Berkeley Street
  • Floor 18
  • Boston, MA 02116
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PAhR Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Jul-2025 $14M Completed Pre-Clinical Trials
To view PAhR Therapeutics’s complete valuation and funding history, request access »

PAhR Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view PAhR Therapeutics’s complete cap table history, request access »

PAhR Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
AN Venture Partners Venture Capital Minority
RA Capital Management Asset Manager Minority
The University of Tokyo Edge Capital Venture Capital Minority
To view PAhR Therapeutics’s complete investors history, request access »

PAhR Therapeutics FAQs

  • When was PAhR Therapeutics founded?

    PAhR Therapeutics was founded in 2025.

  • Where is PAhR Therapeutics headquartered?

    PAhR Therapeutics is headquartered in Boston, MA.

  • What industry is PAhR Therapeutics in?

    PAhR Therapeutics’s primary industry is Drug Discovery.

  • Is PAhR Therapeutics a private or public company?

    PAhR Therapeutics is a Private company.

  • What is the current valuation of PAhR Therapeutics?

    The current valuation of PAhR Therapeutics is .

  • What is PAhR Therapeutics’s current revenue?

    The current revenue for PAhR Therapeutics is .

  • How much funding has PAhR Therapeutics raised over time?

    PAhR Therapeutics has raised $14M.

  • Who are PAhR Therapeutics’s investors?

    AN Venture Partners, RA Capital Management, and The University of Tokyo Edge Capital have invested in PAhR Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process